ANTX vs CVS · $32.0M cap vs P/E 16, rev $402.07B
AN2 Therapeutics Inc (ANTX) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
AN2 Therapeutics Inc (ANTX) is a biotechnology company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
ANTX does not have a complete income-statement cache yet.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
ANTX currently screens at market cap $32.0M. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the ANTX and CVS stock pages for the full models.
Not investment advice.